ASK REDCHAT ANYTHING ABOUT OUTLOOK THERAPEUTICS INC.
Outlook Therapeutics Inc. (NASDAQ: OTLK)
Listen to this Section
$1.59
-0.0950
(
-5.65% )
7.1M
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| ONS-5010 / LYTENAVA™ (bevacizumab-vikg)DetailsWet age-related macular degeneration , Eye diseaseBig Mover™Suspected Mover™Susp. Mover™ |
Phase 3 |
| ONS-5010 / LYTENAVA™ (bevacizumab-vikg)DetailsEye disease |
Phase 3 |
| ONS-5010 / LYTENAVA™ (bevacizumab-vikg)DetailsDiabetes, Eye disease , BK virus, Adenovirus, Epstein-Barr virus, Human herpesvirus 6, Cytomegalovirus, Diabetic macular edema |
Phase 3 |
| ONS-5010 / LYTENAVA™ (bevacizumab-vikg)DetailsEye disease , Wet age-related macular degenerationBig Mover™Suspected Mover™Susp. Mover™ |
Phase 3 |
Market Data
|
| Open |
$1.59 |
| Previous Close |
$1.68 |
| Volume |
7.1M |
| Market Cap |
$249.63M |
| Day Range |
$1.54 - $1.72 |
| 52 Week Range |
$0.16 - $3.39 |
| Shares Outstanding |
148.59M |
| Change % |
-5.65% |
| Net Change |
▼ -0.0950 |
| Insider Ownership |
-0.04% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| IPO Year | 2016 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-4,769,613.29
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-03-08 |
Sale |
-94441.00 |
Huang Andong |
| 2024-03-08 |
Sale |
-94441.00 |
Auffarth Gerd |
| 2024-03-08 |
Sale |
-94441.00 |
Gangolli Julian S |
| 2024-03-08 |
Sale |
-94441.00 |
Haddadin Yezan Munther |
| 2024-03-08 |
Sale |
-94441.00 |
HILZINGER KURT J |
| 2024-03-08 |
Sale |
-94441.00 |
THURMAN RANDY H |
| 2023-10-06 |
Sale |
-370282.00 |
Gangolli Julian S |
| 2023-10-05 |
Sale |
-210225.00 |
Haller Julia A |
| 2023-10-05 |
Sale |
-191113.00 |
Huang Andong |
| 2023-10-05 |
Sale |
-210225.00 |
Auffarth Gerd |
SEC Filings
| Form Type |
Description |
Pages |
Date |
| 8-k |
8K-related |
12 |
Nov 13, 2025 |
| 8-k |
8K-related |
13 |
Nov 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |
| 4 |
Insider transactions |
1 |
Oct 03, 2025 |